The Effects of Calcium Channel Blockers on Cardiovascular Outcomes: a Review of Randomised Controlled Trials

Author： De Leeuw Peter W. Birkenhager Willem H.

ISSN： 0803-7051

Source： Blood Pressure, Vol.11, Iss.2, 2002-03, pp. : 71-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atheroprotective Effects of Long-Acting Dihydropyridine-Type Calcium Channel Blockers: Evidence from Clinical Trials and Basic Scientific Research

Cerebrovascular Diseases, Vol. 16, Iss. 3, 2003-06 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Are Calcium Channel Blockers First-Line Drugs for the Treatment of Hypertension and Cardiovascular Disease?

Current Hypertension Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 9-13

Bentham Science Publishers

Access to resources Recommend Favorite

Calcium channel blockers: an update

By Eisenberg M.J. Brox A. Bestawros A.N.

The American Journal of Medicine, Vol. 116, Iss. 1, 2004-01 ,pp. : 35-43

Elsevier

Access to resources Recommend Favorite

Calcium Channel Blockers and Preconditioning

By Opie L.H.

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 5, 2000-05 ,pp. : 859-860

Academic Press

Access to resources Recommend Favorite

Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials

By Biglia Nicoletta Maffei Silvia Lello Stefano Nappi Rossella E.

Gynecological Endocrinology, Vol. 26, Iss. 11, 2010-11 ,pp. : 804-814

Informa Healthcare

Access to resources Recommend Favorite